01 1Dipharma Francis Srl
01 1Masung LS Co., Ltd.
01 1Selegiline hydrochloride
01 1Italy
Registrant Name : Masung LS Co., Ltd.
Registration Date : 2021-08-19
Registration Number : 20210819-209-J-950
Manufacturer Name : Dipharma Francis Srl
Manufacturer Address : Via Bissone 5 20021 Baranzate (MI), Italy
25
PharmaCompass offers a list of Selegiline Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Selegiline Hydrochloride manufacturer or Selegiline Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Selegiline Hydrochloride manufacturer or Selegiline Hydrochloride supplier.
A Xilopar manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Xilopar, including repackagers and relabelers. The FDA regulates Xilopar manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Xilopar API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Xilopar manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Xilopar supplier is an individual or a company that provides Xilopar active pharmaceutical ingredient (API) or Xilopar finished formulations upon request. The Xilopar suppliers may include Xilopar API manufacturers, exporters, distributors and traders.
click here to find a list of Xilopar suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Xilopar Drug Master File in Korea (Xilopar KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Xilopar. The MFDS reviews the Xilopar KDMF as part of the drug registration process and uses the information provided in the Xilopar KDMF to evaluate the safety and efficacy of the drug.
After submitting a Xilopar KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Xilopar API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Xilopar suppliers with KDMF on PharmaCompass.
